Irhythm Technologies Inc
General ticker "IRTC" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.7B
Irhythm Technologies Inc does not follow the US Stock Market performance with the rate: -20.8%.
Estimated limits based on current volatility of 2.6%: low 86.08$, high 90.62$
Factors to consider:
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [58.48$, 118.99$]
- 2023-12-31 to 2024-12-30 estimated range: [45.52$, 95.26$]
Financial Metrics affecting the IRTC estimates:
- Negative: Non-GAAP EPS, $ of -2.89 <= 0.10
- Negative: Operating profit margin, % of -21.69 <= 1.03
- Negative: Operating cash flow per share per price, % of -0.76 <= 2.35
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0.67 <= 1.08
- Positive: -3.48 < Investing cash flow per share, $ of -1.75
Short-term IRTC quotes
Long-term IRTC plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $322.82MM | $410.92MM | $492.68MM |
| Operating Expenses | $422.77MM | $524.71MM | $617.84MM |
| Operating Income | $-99.94MM | $-113.78MM | $-125.16MM |
| Non-Operating Income | $-1.05MM | $-2.10MM | $2.50MM |
| Interest Expense | $1.17MM | $4.14MM | $3.65MM |
| R&D Expense | $38.67MM | $46.61MM | $60.24MM |
| Income(Loss) | $-100.99MM | $-115.89MM | $-122.66MM |
| Taxes | $0.37MM | $0.27MM | $0.75MM |
| Profit(Loss) | $-101.36MM | $-116.16MM | $-123.41MM |
| Stockholders Equity | $279.51MM | $239.81MM | $210.10MM |
| Inventory | $10.27MM | $15.15MM | $13.97MM |
| Assets | $462.97MM | $448.22MM | $433.14MM |
| Operating Cash Flow | $-37.75MM | $-23.01MM | $-50.10MM |
| Capital expenditure | $28.07MM | $29.83MM | $40.42MM |
| Investing Cash Flow | $105.26MM | $-52.43MM | $-1.21MM |
| Financing Cash Flow | $-28.58MM | $26.72MM | $8.82MM |
| Earnings Per Share* | $-3.46 | $-3.88 | $-4.04 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.